OOCYTE ACTIVATION

"Oocyte activation and human infertility: Identification and characterisation of a critical oocyte-borne receptor, and effects of laboratory procedures upon key proteins involved in oocyte activation"

 Coordinatore THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD 

 Organization address address: University Offices, Wellington Square
city: OXFORD
postcode: OX1 2JD

contact info
Titolo: Ms.
Nome: Gill
Cognome: Wells
Email: send email
Telefono: +44 1865 289800
Fax: +44 1865 289801

 Nazionalità Coordinatore United Kingdom [UK]
 Totale costo 299˙558 €
 EC contributo 299˙558 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2013-IEF
 Funding Scheme MC-IEF
 Anno di inizio 2014
 Periodo (anno-mese-giorno) 2014-04-01   -   2016-03-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

 Organization address address: University Offices, Wellington Square
city: OXFORD
postcode: OX1 2JD

contact info
Titolo: Ms.
Nome: Gill
Cognome: Wells
Email: send email
Telefono: +44 1865 289800
Fax: +44 1865 289801

UK (OXFORD) coordinator 299˙558.40

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

activation    interacts    oocyte    clinical    plc    sperm    infertility    proteins    oad    human    manner    protein    gametes    bovine    deficiency    upon    zeta   

 Obiettivo del progetto (Objective)

'Mammalian sperm activate the oocyte at fertilisation by triggering a calcium-mediated pathway via PLCζ, a sperm-specific phospholipase. PLCζ deficiency is linked to human infertility, a condition that affects 1 in 7 couples. While intra-cytoplasmic sperm injection (ICSI) can rescue many types of male infertility, 1 – 5% of cases fail due to PLCζ-deficiency. While artificial activating agents are available, such chemicals do not initiate activation in an endogenous manner. Recombinant PLCζ thus represents a safer therapeutic option. However, we do not yet know how PLCζ interacts with oocyte-based factors in order to regulate functionality. Current opinion is that an unidentified protein resides within the ooplasm upon vesicles containing the substrate for PLCζ. Identifying this factor, and optimising the manner in which oocyte activation deficiency (OAD) can be diagnosed and treated, is a key clinical remit. Of equal concern is that the host laboratory showed that clinical treatments, such as cryopreservation, can cause detrimental effect upon PLCζ in human sperm. Consequently, this proposal has two objectives: 1) identify the oocyte-factor that interacts with PLCζ via the use of protein-protein interaction technologies, and 2) evaluate the impact of clinical procedures upon gamete proteins that play a critical role during activation. Research will involve human gametes sourced from the Oxford Fertility Unit, along with murine and bovine animal models. The proposal is targeted to (a) improve our understanding of PLCζ function, (b) establish whether the oocyte-interacting protein represents a novel diagnostic marker for OAD, and (c) develop our understanding of how clinical procedures can influence proteins in human gametes. While the proposal is primarily targeted to human reproductive medicine, results will be equally applicable to animals of economic interest, such as the controlled breeding programmes used for equine and bovine species.'

Altri progetti dello stesso programma (FP7-PEOPLE)

PFRPSTRUJOIN (2013)

Structural joints for building frames of pultruded fibre reinforced polymers

Read More  

HTSCS IN PLACENTA (2014)

Origin and lineage specification of trophoblast cells in early human placenta

Read More  

BUMILLA (2013)

Business Model Innovation in Living Labs

Read More